Cancer Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 57.7% | 1.156 | Q1 | 87.3% |
| 2024 | 3.1 | Q2 | 57.1% | 1.201 | Q1 | 88.4% |
| 2023 | 2.9 | Q2 | 50.4% | 1.174 | Q1 | 88.9% |
| 2022 | 4.0 | Q2 | 61.9% | 1.188 | Q1 | 89.8% |
| 2021 | 4.7 | Q3 | 62.6% | 1.144 | Q1 | 89.2% |
| 2020 | — | — | 1.403 | Q1 | 91.5% | |
| 2019 | — | — | 1.315 | Q1 | 90.7% | |
| 2018 | — | — | 1.425 | Q1 | 91.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2045-7634
country
GBcoverage
2012-2026